经导管主动脉瓣置换术后感染自膨胀瓣膜的外科取出回撤技术
本文报道一例82岁男性TAVR术后6个月发生感染性心内膜炎,抗生素治疗3个月后超声提示赘生物及瓣周漏需手术。术中采用聚氯乙烯管回撤保护THV支架框架,减少粘连组织损伤,成功取出感染瓣膜并置换生物瓣。该技术可减少附加操作需求并降低死亡率。
要点
- TAVR术后感染性心内膜炎需手术者可考虑THV取出,但存在粘连组织损伤风险。
- 聚氯乙烯管回撤技术可保护支架框架、减少粘连组织损伤。
- 该技术可能改善预后并减少附加操作需求。
核心结论
- 采用聚氯乙烯管回撤保护THV支架框架可减少粘连组织损伤,成功取出感染瓣膜并置换生物瓣。
- 减少组织损伤的THV取出可降低附加操作风险并带来低死亡率。
研究设计与样本
- 个案报告:82岁男性,有高血压、吸烟史及血脂异常,行TAVR置入29-mm Evolut FX生物瓣。
主要发现
- TAVR术后6个月出现发热,血培养为Streptococcus gordonii,诊断为感染性心内膜炎。
- 抗生素治疗3个月后经食管超声提示赘生物生长及瓣膜漏,需手术。
- 术中切开主动脉,用聚氯乙烯管回撤并保护THV支架框架,帮助分离粘连且组织损伤最小。
- 感染瓣膜成功置换为生物瓣。
临床怎么用
- 对TAVR术后感染性心内膜炎需手术者,可考虑采用聚氯乙烯管回撤技术辅助THV取出以保护粘连组织。
局限性
- 本文为单例个案报告,未报告样本量、随访时长及统计学比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The increasing use of transcatheter aortic valve replacement (TAVR) has led to a rise in cases of infectious endocarditis (IE), a serious complication. For patients who can tolerate surgery, transcatheter heart valve (THV) explantation is considered, though it carries risks of injury to adherent tissues. This report presents a method to minimize such risks during THV removal. An 82-year-old man with hypertension, smoking history and dyslipidaemia underwent TAVR with a 29-mm Evolut FX bioprosthetic valve. Six months later, he developed a fever, and blood cultures revealed Streptococcus gordonii, leading to an IE diagnosis. Despite 3 months of antibiotics, a transoesophageal echocardiogram revealed vegetation growth and valve leakage, necessitating surgery. During the operation, the aorta was incised, and a novel technique using a vinyl chloride tube was employed to retract and protect the THV's stent frame. This approach helped detach adhesions with minimal tissue damage. The infected valve was successfully replaced with a bioprosthetic valve. By reducing adherent tissue injury, this technique could improve patient outcomes and decrease the need for additional procedures. Explantation of THVs with minimal tissue damage reduces the risk of concomitant procedure and results in low mortality.
引用
- Kurosaka K, Iino K, Yamamoto Y, et al. Recapture technique for the surgical explantation of an infected self-expanding prosthesis after transcatheter aortic valve replacement prior to surgical aortic valve replacement. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 40493904. doi:10.1093/icvts/ivaf135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。